Barr Labs Div Teva Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BARR LABS DIV TEVA, and what generic and branded alternatives to BARR LABS DIV TEVA drugs are available?
BARR LABS DIV TEVA has three approved drugs.
Drugs and US Patents for Barr Labs Div Teva
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Barr Labs Div Teva | OXYBUTYNIN | oxybutynin | FILM, EXTENDED RELEASE;TRANSDERMAL | 090526-001 | Mar 4, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Barr Labs Div Teva | ACAMPROSATE CALCIUM | acamprosate calcium | TABLET, DELAYED RELEASE;ORAL | 200143-001 | Nov 18, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Barr Labs Div Teva | BUDESONIDE | budesonide | CAPSULE, DELAYED RELEASE;ORAL | 090379-001 | Apr 2, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.